CEF (Ciclofosfamide, Epirubicina, Fluorouracile) ad alte dosi come chemioterapia primaria nel trattamento del carcinoma mammario localmente avanzato: Risultati a lungo termine

Translated title of the contribution: High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: Long term survival data

F. Conti, S. Carpano, D. Sergi, L. Di Lauro, A. Amodio, P. Vici, M. I. Abbate, F. R. Ferranti, G. Viola, C. Botti, P. Foggi, I. Sperduti, Massimo Lopez

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: Long term survival data'. Together they form a unique fingerprint.

Medicine & Life Sciences